Impaired Endogen Fibrinolysis in Patients with Chronic Ischemic Heart Disease

Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/10252

Full metadata record

DC Field	Value	Language
dc.contributor.author	Nurillaeva Nargiza Mukhtarkhanovna, Zokirova Muborakkhon Bobir qizi	-
dc.date.accessioned	2024-01-16T04:16:45Z	-
dc.date.available	2024-01-16T04:16:45Z	-
dc.date.issued	2023	-
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/10252	-
dc.description.abstract	Cardiovascular disease is one of the main causes of mortality all of the world. Hypercoagulability is one of the pathogenetic mechanisms for the development of coronary heart disease. In our study, the main goal was to evaluate new markers of hypercoagulability and to establish the relationship between risk factors for coronary heart disease. Our results showed that The TAFI level in patients was authentically increased by 2.3 more time in patients compared to healthy individuals. At the same time, we found strong correlation between TAFI and the main risk factors of ischemic heart disease such as ADS, AH, obesity.	en_US
dc.language.iso	en	en_US
dc.publisher	Journal of Survey in Fisheries Sciences	en_US
dc.relation.ispartofseries	10(2S) 2329-2334;	-
dc.subject	Ischemic heart disease, hypercoagulation, Thrombin-activatable fibrinolysis inhibitor (TAFI), risk factors.	en_US
dc.title	Impaired Endogen Fibrinolysis in Patients with Chronic Ischemic Heart Disease	en_US
dc.type	Article	en_US
Appears in Collections:	Thesis, Articles

Files in This Item:

File	Description	Size	Format
3_F_D_A_Нуриллаева_Н_М_,_Зокирова_М_Б_Скопус_ТАФИ_2.pdf	Impaired Endogen Fibrinolysis in Patients with Chronic Ischemic Heart Disease	213.14 kB	Adobe PDF	View/Open

DSpace JSPUI